{"entity":{"type":"insider","cik":"0001408617","url":"/insider/0001408617","json_url":"/insider/0001408617.json","name":"Rackear Andrew D.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":2,"n_filings":2,"first":"2011-11-10","last":"2012-06-06","span_basis":"filed_date"},"name_variants":[{"name":"Rackear Andrew D.","source":"filing","n_filings":2,"first_seen":"2011-11-10","last_seen":"2012-06-06"}],"transactions":[{"id":3270715,"accession":"0000930413-12-003456","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000930413-12-003456","line_url":"/filing/0000930413-12-003456#line-1","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS INC","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":"0001408617","owner_name":"Rackear Andrew D.","owner_display_name":"Rackear Andrew D.","owner_url":"/insider/0001408617","role":"Officer (VP and General Counsel)","role_mark":"O","role_mark_label":"Officer (VP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1614.0,"shares_display":"1,614","price_per_share":6.805,"price_display":"6.80","price_state":"stated","total_value":10983.27,"total_display":"10,983.27","total_whole":"10,983","shares_owned_after":56720.0,"shares_owned_after_display":"56,720","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-06-05","filed_date":"2012-06-06","scope":"insider"},{"id":9107642,"accession":"0000930413-11-007263","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000930413-11-007263","line_url":"/filing/0000930413-11-007263#line-1","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS INC","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":"0001408617","owner_name":"Rackear Andrew D.","owner_display_name":"Rackear Andrew D.","owner_url":"/insider/0001408617","role":"Officer (VP and General Counsel)","role_mark":"O","role_mark_label":"Officer (VP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3766.0,"shares_display":"3,766","price_per_share":6.68,"price_display":"6.68","price_state":"stated","total_value":25156.88,"total_display":"25,156.88","total_whole":"25,157","shares_owned_after":48334.0,"shares_owned_after_display":"48,334","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-10","filed_date":"2011-11-10","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":2,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":2},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000727510","name":"ENZON PHARMACEUTICALS INC","url":"/issuer/0000727510","role":"Officer (VP and General Counsel)","n_filings":2,"first_seen":"2011-11-10","last_seen":"2012-06-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001408617","retrieved_at":"2026-08-23T19:41:43+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}